ad image

Phase I

1 / 1
Firefly Neuroscience
MDD

Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study for Major Depressive Disorder

Firefly Neuroscience

PR-10-24-NI-46Oct 16, 2024
PPD’s Approach to Practical Translational Medicine
Translational Medicine

PPD’s Approach to Practical Translational Medicine

Jeffrey Wheeler; Darin Brimhall, D.O., FACP

PPD, part of Thermo Fisher Scientific

PAO-11-21-CL-03Nov 10, 2021
Pfizer
COVID-19 Vaccine

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2

Pfizer

PR-M06-20-NI-042Jul 02, 2020
Moderna
Coronavirus

Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Vaccine Against Novel Coronavirus

Moderna

PR-M03-20-NI-025Mar 17, 2020
Moderna
Positive Results

Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)

Moderna

PR-M09-19-NI-039Sep 16, 2019
Moderna
Vaccines

Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains

Moderna

PR-M05-19-NI-041May 14, 2019
Gencove
Sequencing

Gencove Announces Phase I SBIR Grant to Validate Polygenic Risk Score Estimation from Low-Pass Sequencing

Gencove

PR-M04-19-NI-092Apr 30, 2019
Kazia Therapeutics Limited
Phase I

Kazia Presents Positive Cantrixil Phase I Data at AACR Conference

Kazia Therapeutics Limited

PR-M04-19-NI-022Apr 05, 2019
“Right To Try” Now Legal Across State Lines
Legislation

“Right To Try” Now Legal Across State Lines

Marc Technow

Nice Insight

PAO-M05-18-NI-026Jun 01, 2018
Mallinckrodt Pharmaceuticals
Clinical Trials

Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft™C9T1 Skin Tissue

Mallinckrodt Pharmaceuticals

PR-M02-18-NI-74Feb 20, 2018
SAB Biotherapeutics, Inc.
Treatment

First Treatment for MERS Appears Safe in NIH Phase I Clinical Trial

SAB Biotherapeutics, Inc.

PR-M01-18-NI-041Jan 15, 2018
Zika Vaccine Candidate Enters Phase I Trial
Clinical Trial

Zika Vaccine Candidate Enters Phase I Trial

Nigel Walker

Nice Insight

PAO-M12-17-NI-008-5007Dec 05, 2017
1 / 1